Evaluation of phenazone oxidation and sulfadimidine acetylation in patients with hematologic neoplasms;Ocena procesów utleniania fenazonu i acetylacji sulfadimidyny u chorych na nowotwory krwi.

Przegla̧d lekarski

Volumn 54, Issue 3, 1997, Pages 163-166

  Wiela Hojenska A ^a   Milejski, P ^a   Orzechowska Juzwenko, K ^a   Usnarska Zubkiewicz, L ^a   Urbaniak Kujda, D ^a   Kotlarek Haus, S ^a  

^a Klinicznej Akadmii Medycznej   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

PHENAZONE; SULFADIMIDINE;

ACETYLATION; ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYMOLOGY; FEMALE; HODGKIN DISEASE; HUMAN; LEUKEMIA; LIVER MICROSOME; MALE; METABOLISM; MIDDLE AGED; NONHODGKIN LYMPHOMA; OXIDATION REDUCTION REACTION; PHENOTYPE;

ACETYLATION; ADOLESCENT; ADULT; AGED; ANTIPYRINE; DISEASE SUSCEPTIBILITY; FEMALE; HODGKIN DISEASE; HUMANS; LEUKEMIA; LYMPHOMA, NON-HODGKIN; MALE; MICROSOMES, LIVER; MIDDLE AGED; OXIDATION-REDUCTION; PHENOTYPE; SULFAMETHAZINE;

EID: 0030632350     PISSN: 00332240     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)